NCT04589429

Adding Nalbuphine for Control of Intrathecal Morphine Pruritus

Does Adding Nalbuphine to Intrathecal Morphine Reduce Morphine Induced Pruritus? A Randomized, Double Blind, Controlled Study.

• Status: Unknown
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 70 (estimated)
• Sponsor: Minia University · Academic / Other
• Sex: All
• Age: 18 Years – 80 Years
• Healthy volunteers: Not accepted

Summary

Intrathecal morphine causes intense itching which is very bothersome. Nalbuphine antagonizes this effect when given intravenously. This trial is to find out if nalbuphine added to intrathecal morphine has an effect on morphine related pruritus while still maintaining adequate analgesia.

Detailed description

The study will be performed in MiniaUniversity Hospitals, after obtaining approval from the local ethics committee. All patients will have a peripheral IV cannula 18 G inserted; standard non-invasive monitors will be applied. Patients undergoing major abdominal surgery will be divided into 2 groups to receive intrathecal morphine 300 micrograms with or without nalbuphine 1mg prior to anesthesia. General anesthesia is then given to patients.

Conditions

• Pruritus
• Pain, Postoperative
• Nausea, Postoperative
• Vomiting, Postoperative

Interventions

Type	Name	Description
DRUG	Morphine 10 MG/ML	intrathecal morphine 300 micrograms
DRUG	Nalbuphine Hydrochloride 10 MG/ML	intrathecal nalbuphine 2mg.

Timeline

• Start date: 2020-10-15
• Primary completion: 2021-03-01
• Completion: 2021-03-01
• First posted: 2020-10-19
• Last updated: 2021-03-01

Locations

1 site across 1 country: Egypt